Justice Pratibha M Singh passed the order while directing Natco to file a response to the injunction application moved by Swiss Pharma…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Category:
India
-
-
IndiaTrade Marks
REMOGLIFLOZIN: INDIA IS THE FIRST COUNTRY TO GET ACCESS TO AN INNOVATIVE TYPE-2 DIABETES DRUG
by adminby adminRemogliflozin was discovered and developed by Japanese firm Kissei Pharmaceutical Co and subsequently developed by GlaxoSmithKline Plc and BHV Pharma, a…
-
Shares in Novartis India gains as much as 5.5% ahead of a Supreme Court hearing on Tuesday. The Indian unit of Novartis AG…
Older Posts